Competitive anxiety in sport
R Martens, RS Vealey, D Burton - 1990 - books.google.com
… As this work began, the coauthors of this book, Robin Vealey and Damon Burton, began
their doctoral studies with Martens at the University of Illinois. As part of their research …
their doctoral studies with Martens at the University of Illinois. As part of their research …
[HTML][HTML] Carbohydrate vaccines: developing sweet solutions to sticky situations?
RD Astronomo, DR Burton - Nature reviews Drug discovery, 2010 - nature.com
Recent technological advances in glycobiology and glycochemistry are paving the way for a
new era in carbohydrate vaccine design. This is enabling greater efficiency in the …
new era in carbohydrate vaccine design. This is enabling greater efficiency in the …
[HTML][HTML] Adolescent idiopathic scoliosis: natural history and long term treatment effects
MA Asher, DC Burton - Scoliosis, 2006 - Springer
… (Reprinted with permission from Asher M, Burton DC: Natürlicher verlauf und
langzeitauswirkungen der idiopathischen adoleszentenskoliose. In Wirbel Säulen Deformitäten: …
langzeitauswirkungen der idiopathischen adoleszentenskoliose. In Wirbel Säulen Deformitäten: …
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Countermeasures to prevent and treat coronavirus disease 2019 (COVID-19) are a global
health priority. We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (…
health priority. We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (…
Complete replication of hepatitis C virus in cell culture
…, CC Liu, T Maruyama, RO Hynes, DR Burton… - Science, 2005 - science.org
Many aspects of the hepatitis C virus (HCV) life cycle have not been reproduced in cell
culture, which has slowed research progress on this important human pathogen. Here, we …
culture, which has slowed research progress on this important human pathogen. Here, we …
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target
…, T Zamb, M Moyle, WC Koff, P Poignard, DR Burton - Science, 2009 - science.org
Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1–infected
individuals, define critical epitopes for HIV vaccine design. Using a systematic approach, we …
individuals, define critical epitopes for HIV vaccine design. Using a systematic approach, we …
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
GJ Hasking, MD Esler, GL Jennings, D Burton… - Circulation, 1986 - Am Heart Assoc
The analysis of plasma kinetics of the sympathetic neurotransmitter norepinephrine can be
used to estimate sympathetic nervous "activity" (integrated nerve firing rate) for the body as a …
used to estimate sympathetic nervous "activity" (integrated nerve firing rate) for the body as a …
Broad neutralization coverage of HIV by multiple highly potent antibodies
…, WC Koff, IA Wilson, DR Burton… - Nature, 2011 - nature.com
Broadly neutralizing antibodies against highly variable viral pathogens are much sought
after to treat or protect against global circulating viruses. Here we probed the neutralizing …
after to treat or protect against global circulating viruses. Here we probed the neutralizing …
Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda
…, SA Iverson, AS Kang, M Alting-Mees, DR Burton… - Science, 1989 - science.org
A novel bacteriophage lambda vector system was used to express in Escherichia coli a
combinatorial library of Fab fragments of the mouse antibody repertoire. The system allows rapid …
combinatorial library of Fab fragments of the mouse antibody repertoire. The system allows rapid …
Robust hepatitis C virus infection in vitro
…, S Kapadia, T Kato, DR Burton… - Proceedings of the …, 2005 - National Acad Sciences
The absence of a robust cell culture model of hepatitis C virus (HCV) infection has severely
limited analysis of the HCV life cycle and the development of effective antivirals and vaccines…
limited analysis of the HCV life cycle and the development of effective antivirals and vaccines…